Inclusion Criteria:  Patients or their legal medical decision makers will sign an informed consent prior to entering the study. Adult patient (≥ 18 years old) with a diagnosis of at least Gleason Grade Group 2 prostate cancer. Appropriate staging investigations have been performed prior to the participation in the study (i.e. CT abdomen/pelvis and 99mTc-MDP bone scan)  Exclusion Criteria:  Unable to obtain consent Weight >250 kg (weight limitation of scanners) Unable to lie flat for 30 minutes to complete the PET or MRI imaging Severe claustrophobia precluding image acquisition Lack of intravenous access Non-MRI compatible pacemaker or hardware eGFR < 40 mL/min/1.73 m2 and/or a history of a severe reaction to MRI contrast Prior androgen deprivation therapy